Non-invasive prenatal paternity testing using mini-STR-based next-generation sequencing: a pilot study
Author:
Song Wenqian1, Xiao Nan1, Zhou Shihang1, Yu Weijian1, Wang Ni1, Shao Linnan1, Liang Xiaohua1ORCID
Affiliation:
1. Dalian Blood Centre , Dalian , P.R. China
Abstract
Abstract
Objectives
To assess the efficacy of a mini-STR-based next-generation sequencing (NGS) method for non-invasive prenatal paternity testing (NIPPT).
Methods
Plasma DNA from 28 pregnant women was extracted and cell-free foetal DNA (cffDNA) genotyping was performed at 23 mini-STR loci using the Illumina NextSeq 500 system. For each mini-STR locus, the cffDNA genotype was validated by determining infant DNA genotype. The mini-STR loci with high concordance rates were selected for the comparison of STR genotyping results between cffDNA and biological father DNA or random male DNA for each family.
Results
The biological relationship was identified between alleged fathers and infants in all 28 families using the capillary electrophoresis (CE) method. Moreover, the concordance rates of STR genotypes D5S818, D19S253, and D21S1270 were less than 50% in 23 autosomal STR loci. The STR genotype matching probability was calculated using 20 STR loci with more than 60% concordance rate. There was a significant difference in the STR genotype matching probability between cffDNA and the DNA from the biological father (75–100%) or from random males (25–70%) (p<0.0001).
Conclusions
Our study demonstrated that mini-STR can be used for NGS-based NIPPT. Furthermore, this method can be used for crime control purposes using the STR data available from the national forensic DNA databases.
Funder
Dalian Municipal Science and Technology Bureau, Dalian, China
Publisher
Walter de Gruyter GmbH
Subject
Biochemistry (medical),Clinical Biochemistry,Discrete Mathematics and Combinatorics
Reference27 articles.
1. Guo, X, Bayliss, P, Damewood, M. A noninvasive test to determine paternity in pregnancy. N Engl J Med 2012;366:1743. https://doi.org/10.1056/nejmc1113044. 2. Beta, J, Lesmes-Heredia, C, Bedetti, C, Akolekar, R. Risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review of the literature. Minerva Ginecol 2018;70:215–9. https://doi.org/10.23736/s0026-4784.17.04178-8. 3. Christiansen, SL, Jakobsen, B, Børsting, C, Udengaard, H, Buchard, A, Kampmann, ML, et al.. Non-invasive prenatal paternity testing using a standard forensic genetic massively parallel sequencing assay for amplification of human identification SNPs. Int J Leg Med 2019;133:1361–8. https://doi.org/10.1007/s00414-019-02106-0. 4. Lo, YM, Corbetta, N, Chamberlain, PF, Rai, V, Sargent, IL, Redman, CW, et al.. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485–7. https://doi.org/10.1016/s0140-6736(97)02174-0. 5. Palomaki, GE, Best, RG. Sequencing cell-free DNA in the maternal circulation to screen for Down syndrome, other common trisomies, and selected genetic disorders. In: Netto, GJ, Kaul, KL, editors. Genomic applications in pathology, 2nd ed. Cham: Springer International Publishing AG; 2019:561–82 pp.
|
|